Pharmacokinetic and pharmacodynamic properties of SOL1: A novel dual inhibitor of neutral endopeptidase and endothelin converting enzyme-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetic and pharmacodynamic properties of SOL1: A novel dual inhibitor of neutral endopeptidase and endothelin converting enzyme

Published:2012-10 Issue:13-14 Volume:91 Page:587-592
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Nelissen J.,Lemkens P.,Sann H.,Bindl M.,Bassissi F.,Jasserand D.,De Mey J.G.R.,Janssen B.J.A.

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference16 articles.

1. Selective indole-based ECE inhibitors: synthesis and pharmacological evaluation;Brands;ChemMedChem,2006

2. Radioimmunoassay evidence that the pressor effect of big endothelin-1 is due to local conversion to endothelin-1;Corder;Biochem Pharmacol,1995

3. Dual endothelin-converting enzyme/neutral endopeptidase inhibition: a novel treatment for renovascular hypertension beyond blood pressure lowering?;Dhaun;Hypertension,2011

4. The endothelins in the pulmonary system;Goldie;Pulm Pharmacol,1996

5. Endothelium-independent pressor effect of big endothelin-1 and its inhibition by phosphoramidon in rat mesenteric artery;Hisaki;Eur J Pharmacol,1993

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The indole motif is essential for the antitrypanosomal activity of N5-substituted paullones;PLOS ONE;2023-11-30

2. Physiological Consequences of Coronary Arteriolar Dysfunction and Its Influence on Cardiovascular Disease: Diagnostic and Additional Therapeutic Consequences;Physiology;2019-03-01

3. Neutral endopeptidase inhibitors blunt kidney fibrosis by reducing myofibroblast formation;Clinical Science;2019-01

4. Dual NEP/ECE inhibition improves endothelial function in mesenteric resistance arteries of 32-week-old SHR;Hypertension Research;2017-03-16

5. Endothelin;Pharmacological Reviews;2016-03-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3